We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
-5.78%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$3.34B
AUM Growth
+$309M
Cap. Flow
+$561M
Cap. Flow %
16.78%
Top 10 Hldgs %
45.09%
Holding
712
New
36
Increased
289
Reduced
298
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Healthcare 8.59%
3 Financials 6.81%
4 Consumer Discretionary 5.49%
5 Industrials 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EG icon
251
Everest Group
EG
$14.8B
$1.42M 0.04%
5,421
+1
+0% +$271
MGM icon
252
MGM Resorts International
MGM
$11.7B
$1.42M 0.04%
47,810
-96
-0.2% -$3.12K
ITW icon
253
Illinois Tool Works
ITW
$78.9B
$1.42M 0.04%
7,849
-304
-4% -$60K
GPN icon
254
Global Payments
GPN
$21.6B
$1.4M 0.04%
12,969
-973
-7% -$120K
MGA icon
255
Magna International
MGA
$18.5B
$1.4M 0.04%
29,469
-530
-2% -$30.9K
HIG icon
256
Hartford Financial Services
HIG
$38.5B
$1.38M 0.04%
22,213
-1,833
-8% -$119K
KMB icon
257
Kimberly-Clark
KMB
$36.3B
$1.34M 0.04%
11,881
+1,912
+19% +$249K
GEN icon
258
Gen Digital
GEN
$15.4B
$1.33M 0.04%
66,214
-4,175
-6% -$96.5K
A icon
259
Agilent Technologies
A
$37.9B
$1.33M 0.04%
10,953
+818
+8% +$105K
IDXX icon
260
Idexx Laboratories
IDXX
$43.2B
$1.32M 0.04%
4,068
+705
+21% +$259K
MRNA icon
261
Moderna
MRNA
$23.2B
$1.32M 0.04%
11,193
-3,136
-22% -$476K
PH icon
262
Parker-Hannifin
PH
$122B
$1.32M 0.04%
5,436
-1,007
-16% -$273K
BIIB icon
263
Biogen
BIIB
$29.7B
$1.31M 0.04%
4,905
-198
-4% -$42.1K
GIS icon
264
General Mills
GIS
$19.7B
$1.29M 0.04%
16,894
-3,888
-19% -$296K
HEES
265
DELISTED
H&E Equipment Services
HEES
$1.29M 0.04%
45,587
TFC icon
266
Truist Financial
TFC
$63B
$1.29M 0.04%
29,551
-9,677
-25% -$466K
PRU icon
267
Prudential Financial
PRU
$41.2B
$1.26M 0.04%
14,690
+661
+5% +$63.6K
NCLH icon
268
Norwegian Cruise Line
NCLH
$8.98B
$1.23M 0.04%
108,280
+22,639
+26% +$298K
DOCS icon
269
Doximity
DOCS
$3.68B
$1.22M 0.04%
40,288
-90
-0.2% -$3.3K
VV icon
270
Vanguard Large-Cap ETF
VV
$52.6B
$1.22M 0.04%
7,448
+5,164
+226% +$939K
VHT icon
271
Vanguard Health Care ETF
VHT
$17.9B
$1.21M 0.04%
5,418
+2,709
+100% +$647K
MSCI icon
272
MSCI
MSCI
$41.4B
$1.21M 0.04%
2,866
+324
+13% +$148K
DG icon
273
Dollar General
DG
$26.7B
$1.21M 0.04%
5,032
-225
-4% -$55.5K
PPG icon
274
PPG Industries
PPG
$26.1B
$1.21M 0.04%
10,894
+255
+2% +$31.5K
VGSH icon
275
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$1.2M 0.04%
20,758
+10,379
+100% +$608K

Similar funds

RegentAtlantic Capital's Q3 2022 Portfolio in Review

As of Q3 2022, RegentAtlantic Capital held 712 positions worth $3.34B, up 10% from $3.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

RegentAtlantic Capital deployed $561M of net new capital in Q3 2022, opening 36 new positions and adding to 289 existing holdings. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 366,271 shares worth $36.6M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $67.8M trimmed.

  • RegentAtlantic Capital's largest Q3 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 366,271 shares worth $36.6M.
  • RegentAtlantic Capital added most to Vanguard S&P 500 ETF in Q3 2022, an estimated $215M increase.
  • RegentAtlantic Capital's biggest Q3 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $67.8M.
  • RegentAtlantic Capital fully exited iShares MSCI Emerging Markets ex China ETF in Q3 2022, selling an estimated $4.23M.
  • RegentAtlantic Capital's ten largest holdings make up 45% of its $3.34B portfolio in Q3 2022.
  • RegentAtlantic Capital opened 36 new positions and closed 46 in Q3 2022.
  • RegentAtlantic Capital's portfolio value rose 10% quarter-over-quarter to $3.34B.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.